We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 7.14% | 7.50 | 7.30 | 7.70 | 7.75 | 7.25 | 7.25 | 2,321,457 | 15:18:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.35 | 45.02M |
TIDMKMK
RNS Number : 0987N
Kromek Group PLC
27 September 2021
27 September 2021
Kromek Group plc
("Kromek" or the "Group")
Director Share Purchase
Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that Rakesh Sharma, Non-Executive Chairman, has today purchased 94,339 ordinary shares of 1 pence each in the Group ("Ordinary Shares") at a price of 15.90 pence per Ordinary Share.
Following this purchase, Mr Sharma has an interest in 469,195 Ordinary Shares, representing 0.11% of the issued share capital of the Group.
For further information, please contact:
Kromek Group plc Arnab Basu, CEO Paul Farquhar, CFO +44 (0)1740 626 060 Cenkos Securities plc (Nominated Adviser and Broker) Camilla Hume/Giles Balleny (NOMAD) Julian Morse (Sales) +44 (0)20 7397 8900 Luther Pendragon (PR) Harry Chathli/Claire Norbury +44 (0)20 7618 9100
About Kromek Group plc
Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over 150 full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.
The Group makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Rakesh Sharma ------------------------- ------------------------------------- 2 Reason for the notification ---------------------------------------------------------------- a) Position/status Non-Executive Chairman ------------------------- ------------------------------------- b) Initial Initial notification notification /Amendment ------------------------- ------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------------------- a) Name Kromek Group plc ------------------------- ------------------------------------- b) LEI 213800VLHYXGHEX5VQ48 ------------------------- ------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------- a) Description Ordinary Shares of 1p each of the financial instrument, type of GB00BD7V5D43 instrument Identification code ------------------------- ------------------------------------- b) Nature of Purchase of Ordinary Shares the transaction ------------------------- ------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) 15.90 pence 94,339 ---------- ------------------------- ------------------------------------- d) Aggregated information N/A - Aggregated volume - Price ------------------------- ------------------------------------- e) Date of 27 September 2021 the transaction ------------------------- ------------------------------------- f) Place of London Stock Exchange the transaction ------------------------- -------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAANXALKFEFA
(END) Dow Jones Newswires
September 27, 2021 08:47 ET (12:47 GMT)
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions